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The generation of the human iPSC line, Oex2054SV.4, was carried
out using non-integrative Sendai viruses containing the reprogramming
factors, OCT3/4, SOX2, CMYC, KLF4 (Takahashi et al., 2007). For this pur-
pose, ﬁbroblasts from a patient with an optic atrophy ‘plus’ phenotype
were obtained (Amati-Bonneau et al., 2008). The patient's ﬁbroblasts
carried a heterozygous mutations in the OPA1 gene (c.1861CNT;
p.Gln621Ter). The presence of this mutation in the iPSC line was evalu-
ated and conﬁrmed by Sanger sequencing (Fig. 1A). Oex2054SV.4 iPSC
colonies displayed a typical ES-like colony morphology and growth
behavior (Fig. 1B) and they stained positive for alkaline phosphatase ac-
tivity (Fig. 1C).We conﬁrmed the clearance of the vectors and the exog-
enous reprogramming factor genes by RT-PCR after eight culture
passages (Fig. 1D). The endogenous expression of the pluripotency as-
sociated transcription factors OCT4, SOX2, KLF4, NANOG, CRIPTO and
REX1was also evaluated by RT-PCR (Fig. 1E). Immunoﬂuorescence anal-
ysis revealed expression of transcription factorsOCT4,NANOG, SOX2 and
surface markers SSEA3, SSEA4, TRA1-60 and TRA1-81 characteristics of
pluripotent ES cells (Fig. 1F). Promoters of the pluripotency associated
genes, OCT4 and NANOG, heavily methylated in the original ﬁbroblasts
were almost demethylated in the Oex2054SV.4 line suggesting an epi-
genetic reprogramming to pluripotency (Fig. 1G). The iPSC line has
been adapted to feeder-free culture conditions and displays a normal
karyotype (46, XY) after more than twenty culture passages (Fig. 1H).
We also conﬁrmed by DNA ﬁngerprinting analysis that the line
Oex2054SV.4was derived from the patient'sﬁbroblasts (Fig. 1I). Finally,(http://creativecommons.org/licenses/by-nc-nd/4.0/).
674 T. Galera-Monge et al. / Stem Cell Research 16 (2016) 673–676the capacity of the generated iPSC line to differentiate into the three
germ layers (endoderm, mesoderm and ectoderm) was tested in vitro
using an embryoid body based assay (Fig. 1J).
Materials and methods
Non-integrative reprogramming of mutant OPA1 ﬁbroblasts into iPSC
All the experimental protocols included in the present study were
approved by the Institutional Ethical Committee of the Autonoma Uni-
versity of Madrid according to Spanish and European Union legislation.
Human ﬁbroblasts from a patient presenting with a severe mitochon-
drial encephalopathy associated with mutations in the OPA1 gene
were used. For this purpose tissue fragments were obtained from a
skin biopsy of this patient after informed consent. These fragments
were directly plated in a dishwithDMEMhigh glucosewith 10%deﬁned
fetal bovine serum (Hyclone), 2 mM GlutaMAX and 1X Penicillin-
Streptomycin (Life Technologies). After 3–4weeks,ﬁbroblasts outgrow-
ing from the biopsy pieceswill covermost of the dish andwere expand-
ed at 37 °C in 5% CO2 until the second passage. Subsequently, these
ﬁbroblasts were reprogrammed using the CytoTune-iPS 2.0 Sendai
reprogramming kit following the instructions of the manufacturer.
After eight passages of the iPSC line, silencing of the exogenous
reprogramming factors genes and sendai virus genome was conﬁrmed
by RT-PCR following the manufacturer’s instructions. Oex2054SV.4
was maintained and expanded both on feeder layers and on feeder-
free layers. In the ﬁrst case, irradiated human ﬁbroblasts feeders with
ES medium containing: Knockout DMEM (Life technologies), Knockout
serum replacement 20%, (Life technologies), MEM non-essential amino
acids solution 1X (Life technologies), GlutaMAX 1X (Life technologies),
β-mercaptoethanol (100 μM), penicillin/streptomycin 1X (Life technol-
ogies) and bFGF (4ng/ml) (Miltenyi Biotec) were used. Subsequently,
Oex2054SV.4 was adapted and cultured in feeder-free conditions on
matrigel (354277, Corning)withmTeSR1medium (StemCell) following
the recommendations of the manufacturer. For the propagation of the
line, both enzymatic (dispase, collagenase IV and accumax) and me-
chanical procedures have been used.
Phosphatase alkaline analysis
The iPSC line Oex2054SV.4 was seeded on a feeder layer plate. After
seven days direct phosphatase alkaline activity was determined using
the phosphatase alkaline blue membrane substrate solution kit
(Sigma, AB0300) following the instructions of the manufacturer.
Mutation analysis
Total DNA from the patient’s ﬁbroblasts and iPSCs was extracted
using a standard phenol-chloroform protocol. Subsequently, ampliﬁca-
tion by PCR of theOPA1 gene region containing the c.1861CNTmutation
was carried out using the following primers: (OPA1-20F: 5′-TATTATAA
GTTAATGATACTTCAG-3′ and OPA1-20R: 5′-GTAGCAACATTAAGGTTA
GTC-3′). Following PCR ampliﬁcation, direct sequencing of amplicons
was performed on both strands in an ABI 3730 sequencer (Applied
Biosystems; Foster City, CA) using a dye terminator cycle sequencing
kit (Applera, Rockville, MD).
qPCR analyses
Total mRNAwas isolated using TRIZOL and 1 μg was used to synthe-
size cDNA using theQuantitect reverse transcription cDNA synthesis kit.
One microliter of the reaction was used to quantify by qPCR the expres-
sion of the endogenous pluripotency associated genes (OCT4, SOX2,
KLF4, NANOG, CRIPTO and REX1). Primers sequences were described by
Aasen et al., 2008. All the expression values were normalized to theGAPDH housekeeping gene. Plots are representative of at least three
independent experiments.
Bisulﬁte pyrosequencing
Bisulﬁte modiﬁcation of genomic DNA was performed with
the EZ DNA Methylation-Gold kit (Zymo Research) following the
manufacturer's instructions. The set of primers for PCR ampliﬁcation
and sequencing of NANOG and OCT4 were designed using the software
PyroMark Assay Design (version 2.0.01.15; Qiagen): Forward-NANOG
(5′-TAT TGG GAT TAT AGG GGT GGG TTA-3′), Reverse-NANOG (5′-
[Btn]-CCC AAC AAC AAA TAC TTC TAA ATT CAC-3′), and sequencing
primer S-NANOG (5′-ATA GGG GTG GGT TAT-3′); Forward-OCT4_prox
(5′-GGG GTT AGA GGT TAA GGT TAG TG-3′), Reverse-OCT4_prox (5′-
[Btn]-ACC CCC CTA ACC CAT CAC-3′), and sequencing primer S-
OCT4_prox (5′-GGG GTT GAG TAG TTT-3′); Forward-OCT4_dist (5′-TTT
TTG TGG GGG ATT TGT ATT GA-3′), Reverse-OCT4_dist (5′-[Btn]-AAA
CTA CTC AAC CCC TCT CT-3′), and sequencing primer S-OCT4_dist (5′-
ATT TGT ATT GAG GTT TTG GA-3′). PCR was performed with primers
biotinylated to convert the PCR product to single-stranded DNA tem-
plates, using the Vacuum Prep Tool. After PCR ampliﬁcation, pyrose-
quencing reactions and methylation quantiﬁcation were performed
using PyroMark Q24 reagents, equipment and software (version 2.0.6;
Qiagen), according to the manufacturer’s instructions.
Karyotype analysis
Karyotype analyses of the iPSC line were carried out using cells
with more than twenty culture passages. These cells were processed
using standard cytogenetic techniques. Brieﬂy, cells were treated with
10μg/ml of Colcemid (Gibco) for 90 min at 37 °C, trypsinized, treated
with 0.075 M hypotonic KCl solution, and ﬁxed with Carnoy's ﬁxative.
Cells were then dropped on a microscope glass slide and dried.
Metaphase cells were G banded using Wright staining. At least 20
metaphases were karyotyped.
Immunoﬂuorescence analysis
Cells were grown on 0.1% gelatin-coated P35 culture plates (81156,
Ibidi) and ﬁxed with 4% paraformaldehyde. The following antibodies
for the staining were used: TRA-1-60 (Millipore; MAB4360; 1:150);
TRA-1-81 (Millipore; MAB4381; 1:150); SOX2, (Thermo Scientiﬁc;
PA116968; 1:100); NANOG (R&D Systems; AF1997; 1:25); SSEA-4
(Millipore; MAB4304; 1:10); SSEA-3 (Millipore; MAB4303; 1:10);
OCT4 (Santa Cruz Biotechnology; Sc-5279; 1:100); neuron-speciﬁc
class III beta-tubulin (Tuj1) (Sigma, T8660, 1:300), α-fetoprotein
(AFP) (Sigma, WH0000174M1, 1:300), smooth muscle alpha actin
(SMA) (Sigma, A2547, 1:400). Secondary antibodies used were all
from the Alexa Fluor Series from Jackson Immunoresearch (all 1:500).
Images were taken using a Zeiss confocal microscope.
In vitro differentiation assay
The in vitro pluripotency capacity of the iPSC line was tested by
spontaneous embryoid body differentiation. For this purpose, iPSCs
from a P100 plate with 80% of conﬂuencywere dissociated into a single
cell suspension with accumax (SCR006,Millipore) and resuspended in
12 ml of mTeSR1 medium (Stemcell). Embryoid body formation was
induced by seeding 120 μl of the iPSC suspension in each well of
96-well v-bottom low attachment plates and centrifuging the plates at
800 g for 10 min to aggregate the cells. After 2–3 days the embryoid
bodies were transferred to an untreated P60 culture plate for 2–
4 days. Subsequently, the embryoid bodies were transferred to 0.1%
gelatin-coated P35 culture plates (81156, Ibidi) and cultured in differen-
tiation medium (DMEM F12 supplemented with 20% fetal bovine
serum, 2 mM glutamine, 0.1 mM β-mercaptoethanol, 1X non essential
Fig. 1.Molecular and functional characterization of the Oex2054SV.4 iPSC line. A. Electropherograms showing the mutation in the patient's ﬁbroblasts and in the Oex2054SV.4 line. B.
Typical ES-like colony morphology of the Oex2054SV.4 iPSC line. C. Positive phosphatase alkaline staining. D. RT-PCR for detecting the clearance of the vectors and the exogenous
reprogramming factor genes. E. QPCR showing the expression of thepluripotency associatedmarkersNANOG,OCT4, SOX2,KLF4, CRIPTO andREX1. F. Immunoﬂuorescence analysis showing
expression of typical pluripotent ES cellmarkers such as the transcription factors OCT4, NANOG, SOX2 and the surfacemarkers SSEA3, SSEA4, TRA1-60 and TRA1-81; scale bars: 300 μm. G.
Bisulﬁte pyrosequencing of the OCT4 and NANOG promoters. The promoters of the transcription factors, OCT4 and NANOG, were almost demethylated in the generated iPSC line. H.
Karyotype analysis. Oex2054SV.4 has a normal karyotype (46, XY). I. DNA ﬁngerprinting analysis showing that Oex2054SV.4 comes from the patient's ﬁbroblasts. J. Embryoid body
based in vitro differentiation assays. Oex2054SV.4 differentiates into all three germ layers, demonstrated by positive AFP endoderm staining, positive Tuj1 ectoderm staining and positive
SMA mesoderm staining.
675T. Galera-Monge et al. / Stem Cell Research 16 (2016) 673–676amino acids and 1X penicillin-streptomycin, all from Invitrogen) for
2–3 weeks to allow spontaneous endoderm formation. For mesoderm
differentiation, iPSCs were maintained for 2–3 weeks in differentiation
medium supplemented with 100 μM ascorbic acid (A4403, Sigma-Aldrich). For ectoderm differentiation, embryoid bodies were trans-
ferred tomatrigel coated P35 culture plates and cultured in a special dif-
ferentiation medium containing (50% DMEM F12, 50% neurobasal
medium, 1X GlutaMAX, 1X penicillin-streptomycin, non essential
676 T. Galera-Monge et al. / Stem Cell Research 16 (2016) 673–676aminoacids, 0.1mM2-mercaptoethanol, 1XN2 supplement and 1X B27
supplement, all from Invitrogen). In all the cases, the medium was
changed every other day.
DNA ﬁngerprinting analysis
For DNA ﬁngerprinting analysis, highly polymorphic regions con-
taining short tandem repeated sequences of DNA have been evaluated.
For this purpose, the following markers (D13S317, D7S820, VWA,
D8S1179, D21S11, D19S433, D2S1338 and amelogenin for sex determi-
nation) have been ampliﬁed by PCR and analyzed by ABI PRISM 3100
Genetic analyzer and Peak Scanner v3.5 (Applied Biosystems). Primer
sequences and PCR conditions are available upon request.
Author disclosure statement
There are no competing ﬁnancial interests in this study.
Acknowledgments
This work was supported by grants from the “Centro de
Investigación Biomédica en Red en enfermedades raras” (CIBERER)
(Grant 13-717/132.05 to RG), the “Instituto de Salud Carlos III” [Fondo
de Investigación Sanitaria and European Regional Development Fund(ERDF/FEDER) funds PI10/0703 and PI13/00556 to RG and PI15/00484
to MEG], “Comunidad Autónoma de Madrid” (grant number S2010/
BMD-2402 to R.G); T.G-M. receives grant support from the Universidad
Autónoma de Madrid, FPI-UAM and F.Z-D from the Ministerio de
Educación, Cultura y Deporte, grant number FPU13/00544. M.E.G. is
staff scientist at the “Centro de Investigación Biomédica en Red en
Enfermedades Raras” (CIBERER).
References
Aasen, T., Raya, A., Barrero, M.J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilić, J.,
Pekarik, V., Tiscornia, G., Edel, M., Boué, S., 2008. Izpisúa Belmonte J.C. Efﬁcient and
rapid generation of induced pluripotent stem cells from human keratinocytes. Nat.
Biotechnol. 26 (11), 1276–1284.
Amati-Bonneau, P., Valentino, M.L., Reynier, P., Gallardo, M.E., Bornstein, B., Boissière, A.,
Campos, Y., Rivera, H., de la Aleja, J.G., Carroccia, R., Iommarini, L., Labauge, P.,
Figarella-Branger, D., Marcorelles, P., Furby, A., Beauvais, K., Letournel, F., Liguori, R.,
La Morgia, C., Montagna, P., Liguori, M., Zanna, C., Rugolo, M., Cossarizza, A.,
Wissinger, B., Verny, C., Schwarzenbacher, R., Martín, M.A., Arenas, J., Ayuso, C.,
Garesse, R., Lenaers, G., Bonneau, D., Carelli, V., 2008. OPA1 mutations induce mito-
chondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 131 (Pt 2),
338–351.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S.,
2007. Induction of pluripotent stem cells from adult human ﬁbroblasts by deﬁned
factors. Cell 131 (5), 861–872.
